As previously disclosed, the company is updating 2025 financial guidance to reflect the Passenger business divestiture throughout all periods in 2025. Beginning with the Q3 2025 earnings report, the Passenger business will be reported in discontinued operations. For the full year 2025: Revenue of $160-170M; Double-digit Adjusted EBITDA. Adjusted unallocated corporate expenses and software development costs are expected to decrease to a quarterly run rate of approximately $3.5M in Q4 2025.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLDE:
- Blade Air Mobility completes sale of Passenger business, name change
- Ten new option listings and three option delistings on August 29th
- Blade Air Mobility sets timing for name change to Strata Critical Medical
- Third Point discloses activist 6.1% stake in Blade Air Mobility
- CRSP, TWST: Cathie Wood Bets Millions on Biotech, Continues Dumping Roblox